{"filings":[{"id":40288,"accession_number":"0001437749-26-016422","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2026-05-12T20:06:45+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Electromed posts record Q3 FY2026 revenue $18.6M (+18% YoY); EPS $0.35 (+59%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $18.6M (+18.4% YoY); homecare revenue $16.7M (+18.6%) driven by 57 direct sales reps.","Operating income $3.8M (+76.0% YoY, 20.3% of revenue); net income $3.0M, $0.35 diluted EPS.","Cash $17.0M, no debt; working capital $40.0M; shareholders' equity $49.2M.","14th consecutive quarter of YoY revenue and profit growth; 86% of covered lives under contract."],"consensus_eps_estimate":null,"consensus_eps_actual":0.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":54359000.0,"consensus_period":"2026-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104526,"accession_number":"0001437749-26-003636","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2026-02-10T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Electromed reports record Q2 FY2026: revenue up 16.3% to $18.9M, EPS $0.32 vs $0.22 YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue record $18.9M (+16.3% YoY); homecare revenue up 18.4% to $17.3M.","Record net income of $2.8M ($0.32 diluted EPS), up 40.3% from $2.0M ($0.22) YoY.","Operating income record $3.6M (19.2% margin), +42.4% YoY.","Repurchased $2.8M of stock in Q2 at avg $26.16; cash $13.8M, no debt.","13th consecutive quarter of YoY revenue and net income growth."],"consensus_eps_estimate":null,"consensus_eps_actual":0.56,"consensus_revenue_estimate":null,"consensus_revenue_actual":35784000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120810,"accession_number":"0001437749-25-038291","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2025-12-18T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Electromed enters $10M revolving credit facility with BMO Bank N.A., maturing December 2026","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$10M revolving line of credit at 1-month Term SOFR plus 1.75%, maturing December 16, 2026.","First-priority security interest granted on substantially all existing and future assets.","Financial covenants: Fixed Charge Coverage Ratio ≥ 1.20x; Total Funded Debt/EBITDA ≤ 2.50x when drawn.","Proceeds used for capital expenditures, working capital, and general corporate purposes.","Existing credit facility with Choice Financial Group terminated in connection with this new facility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120809,"accession_number":"0001437749-25-035598","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2025-11-18T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Electromed shareholders elect all eight director nominees and ratify RSM as auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All eight director nominees elected with >95% of votes cast; broker non-votes ~1.4M.","Ratification of RSM US LLP as auditor approved with 6,435,180 for, 5,610 against.","Non-binding say-on-pay approved: 4,713,558 for, 309,673 against, 1.4M broker non-votes.","Shareholders recommended annual say-on-pay frequency (4,783,259 votes); board adopts annual frequency."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120808,"accession_number":"0001437749-25-034438","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2025-11-12T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Electromed Q1 FY2026 revenue up 15% to $16.9M; EPS $0.25 vs $0.16","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues of $16.9M (+15.1% YoY); net income of $2.1M (+44.9%); diluted EPS $0.25 (vs $0.16).","Homecare direct revenue $14.9M (+12.7%); hospital revenue $1.047M (+51.7%); distributor $0.829M (+41.2%).","Operating income $2.7M (+37.8%); gross margin 78.1% (vs 78.3% prior year); SG&A $10.3M (+9.6%).","Cash $14.1M, no debt; board approved $10M stock repurchase authorization; $1.0M repurchased in Q1.","Twelfth consecutive quarter of year-over-year revenue and net income growth; 57 homecare direct reps avg."],"consensus_eps_estimate":0.2462,"consensus_eps_actual":0.25,"consensus_revenue_estimate":null,"consensus_revenue_actual":16887000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137410,"accession_number":"0001437749-25-028605","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2025-09-09T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Electromed authorizes $10M share repurchase program","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized up to $10M in common stock repurchases on Sept 9, 2025.","Program follows exhaustion of prior authorization in Q4 FY2025.","Repurchases may occur on open market or in private transactions at management's discretion.","CEO cites strong operational performance and cash reserves as rationale.","Board will periodically review and may adjust program terms."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137409,"accession_number":"0001437749-25-027760","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2025-08-26T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Electromed posts record Q4 revenue $17.4M (+17%); full-year net income $7.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 FY2025 revenue $17.4M (+17.3% YoY); operating income $3.0M (+30.2%); diluted EPS $0.25 (vs $0.20).","FY2025 revenue $64.0M (+17.0%); operating income $9.7M (+46.8%); net income $7.5M ($0.85 diluted EPS).","Share repurchases totaled $10.0M during FY2025; cash $15.3M and no debt at June 30, 2025.","Direct homecare revenue grew 14.8% in Q4; total field sales reps reached 62.","Added to Russell 2000 and 3000 indexes in June 2025."],"consensus_eps_estimate":0.273,"consensus_eps_actual":0.85,"consensus_revenue_estimate":null,"consensus_revenue_actual":64000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154720,"accession_number":"0001437749-25-016436","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2025-05-13T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Electromed Q3 FY2025 revenue up 13.1% to $15.7M; EPS $0.21 vs $0.17, tenth consecutive growth quarter","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $15.7M (+13.1% YoY); direct homecare revenue $14.1M (+14.8%).","Net income $1.9M ($0.21 diluted EPS) vs $1.5M ($0.17) prior year; operating income $2.1M (+16.2%).","Gross margin expanded to 78.0% from 74.8% driven by higher net revenue per device.","Board authorized $5M share repurchase in Q3; YTD repurchases ~$6.3M; cash $15.2M, no debt.","Operating cash flow $7.5M YTD, up $3.0M YoY; VA direct-to-consumer outreach in 11 cities launched."],"consensus_eps_estimate":null,"consensus_eps_actual":0.59,"consensus_revenue_estimate":null,"consensus_revenue_actual":46607000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173240,"accession_number":"0000897101-25-000125","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Electromed board authorizes $5.0M stock repurchase program","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized up to $5.0 million in share repurchases on March 6, 2025.","Repurchases may be made on open market or privately negotiated.","CEO Jim Cunniff cites confidence in business and commitment to shareholder value."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173239,"accession_number":"0000897101-25-000088","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2025-02-11T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Electromed Q2 FY2025 revenue up 18.7% to record $16.3M; net income $2.0M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue rose 18.7% YoY to $16.3M; operating income record $2.5M (15.6% margin).","Net income $2.0M ($0.22 diluted EPS) vs. $1.7M ($0.19) in Q2 FY2024.","Direct homecare revenue grew 15.2% to $14.6M; sales force ended at 54 reps.","Cash $16.2M, no debt; share repurchases of $4.5M in H1 FY2025.","Gross margin improved to 77.7% from 77.0%; SG&A rose 20.3% on higher headcount."],"consensus_eps_estimate":0.221,"consensus_eps_actual":0.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":30923000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190257,"accession_number":"0000897101-24-000581","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2024-11-18T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Electromed shareholders re-elect all eight directors, ratify auditor, approve say-on-pay","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All eight director nominees elected (e.g., Cunniff 5,150,638 for; Skarvan 5,050,697 for).","RSM US LLP ratified as auditor for FY ending June 30, 2025: 6,370,993 for, 1,718 against.","Non-binding advisory vote on executive compensation approved: 4,645,654 for, 486,736 against.","Bylaws amended for non-substantive, conforming gender-neutral pronoun updates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190256,"accession_number":"0000897101-24-000562","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Electromed Q1 FY2025 revenue up 19% to $14.7M; net income $1.5M vs $0.2M YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Diluted EPS $0.16 vs $0.02 prior year; operating income $1.9M (13.2% rev) vs $0.1M.","Gross margin improved to 78.3% from 77.1%; direct homecare revenue rose 18.5% to $13.2M.","Repurchased 262,756 shares for ~$4.5M at avg $17.26; $0.5M remaining on $5M authorization.","Direct sales force of 53 reps; hired VP Marketing Peter Horwich; launched Triple Down on Bronchiectasis campaign.","Cash $13.9M, no debt; annualized homecare revenue per rep $985,000 (within $900k-$1M target)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":14668000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206762,"accession_number":"0000897101-24-000443","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2024-09-11T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Electromed authorizes $5.0 million share repurchase program","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized repurchase of up to $5.0M of common stock, effective September 11, 2024.","New authorization follows exhaustion of prior repurchase program in Q4 fiscal 2024.","Repurchases may occur on open market or in private transactions, at management's discretion.","CEO Jim Cunniff cited strong FY2024 results and belief stock is undervalued as rationale.","Authorization reinforces commitment to shareholder returns while continuing to invest in the business."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206761,"accession_number":"0000897101-24-000421","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2024-08-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Electromed delivers record FY2024 revenue $54.7M, net income $5.2M ($0.58/sh)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenue $14.8M (+9% YoY); operating income $2.3M (+56.3%); diluted EPS $0.20 vs $0.12.","FY2024 net revenue $54.7M (+13.8%); operating income $6.6M (+64.2%); net income $5.2M ($0.58 dil EPS) vs $3.2M ($0.36).","Gross margin stable at 76.3% for FY; cash $16.1M, no debt; working capital $36.5M.","Homecare revenue per weighted avg direct sales rep $967K, above target range of $850K-$950K.","CEO cites market share gains and infrastructure investments; optimistic for FY2025."],"consensus_eps_estimate":null,"consensus_eps_actual":0.58,"consensus_revenue_estimate":null,"consensus_revenue_actual":54716000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206760,"accession_number":"0000897101-24-000346","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Electromed to Present at Canaccord Genuity 44th Annual Global Growth Conference on August 14, 2024","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Jim Cunniff (CEO) and Brad Nagel (CFO) attending conference in Boston, August 13-15, 2024.","Management presentation at 2:30 p.m. ET on Wednesday, August 14, 2024.","Updated investor presentation deck published on company and SEC websites.","SmartVest® Airway Clearance System highlighted as core product."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223989,"accession_number":"0000897101-24-000162","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Electromed reports record Q3 revenue of $13.9M, up 15% YoY; net income $0.17 diluted EPS vs $0.12","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue rose 14.9% YoY to a record $13.9M; net income $1.493M ($0.17 diluted) vs $1.075M ($0.12).","Operating income increased 54% to $1.841M (13% of revenue); gross margin held at 75%.","Direct homecare revenue grew 12% to $12.3M; 51 direct sales reps; annualized revenue per rep $969K above target range.","Cash balance $11.7M, up $4.3M in nine months; no debt; working capital $35.0M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":39884000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243347,"accession_number":"0000897101-24-000069","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2024-02-13T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Electromed Q2 FY2024 revenue record $13.7M (+17% YoY), EPS $0.19 vs $0.11","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue increased 17% to record $13.7M; direct homecare revenue up 18% to $12.7M.","Gross margins improved to 77% from 74%; operating income record $2.263M (16.5% of revenue).","Diluted EPS $0.19 vs $0.11; net income record $1.674M.","Cash $10.4M, no debt; annualized homecare revenue per rep $1,007,000 above target range.","Field sales force totaled 58, with 49 direct sales representatives."],"consensus_eps_estimate":null,"consensus_eps_actual":0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":26013000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":260745,"accession_number":"0000897101-23-000540","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2023-12-15T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Electromed renews $2.5M revolving credit facility with Choice Financial Group through Dec 2025","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Revolving line of credit renewed at $2,500,000, maturing December 18, 2025 (extended 2 years).","Borrowing base limited to 57% of eligible accounts receivable; interest at prime minus 1.00%, no floor.","Rider adds 5-day grace on payment defaults, $1M materiality threshold for cross-defaults.","Loan remains secured by substantially all tangible and intangible assets of the company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":260744,"accession_number":"0000897101-23-000503","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2023-11-15T23:59:59+00:00","items":["5.07","7.01","9.01"],"status":"ready","headline":"Electromed shareholders elect eight directors and approve equity plan at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All eight director nominees elected; average 'For' votes ~3.9M, broker non-votes 1.28M.","2023 Equity Incentive Plan approved: 3.90M For, 147K Against, 19.8K Abstain.","RSM US LLP ratified as independent auditor for FY2024: 5.26M For, 44.8K Against.","Advisory vote on executive compensation approved: 3.99M For, 54.9K Against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":260743,"accession_number":"0000897101-23-000476","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2023-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Electromed Q1 FY2024: revenue $12.3M (+16%), EPS $0.02, operating income $142K","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $12.3M, up 16% YoY; homecare revenue $11.2M (+15.8%).","Net income $155K ($0.02 diluted EPS) vs $81K ($0.01) YoY.","Operating income $142K vs $44K; gross margin 77.1% (down from 78.2%).","Cash $7.0M, no debt, working capital $30.4M.","Sales force 59; annualized homecare revenue per rep $876K within $850-950K target."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":12324000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":278029,"accession_number":"0000897101-23-000379","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2023-08-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Electromed reports record FY2023 revenue of $48.1M; Q4 EPS $0.12 vs $0.04 YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $13.6M (+21% YoY); net income $1.0M ($0.12 EPS) vs $0.4M ($0.04).","Full year revenue $48.1M (+15% YoY); net income $3.2M ($0.36 EPS) vs $2.3M ($0.26).","Home care revenue up 15.6% to $44.0M; sales rep count 55 (46 direct); productivity $945K per rep.","Cash $7.4M, no debt; working capital $29.7M; shareholders' equity $37.7M.","Jim Cunniff assumes role of President & CEO; Kathleen Skarvan becomes Board Chair; launched SmartVest Clearway."],"consensus_eps_estimate":null,"consensus_eps_actual":0.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":48067000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":296095,"accession_number":"0000897101-23-000248","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2023-06-15T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Electromed CCO Christopher Holland to depart June 23; receives $117,937 severance plus accelerated vesting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Christopher G. Holland's employment ends June 23, 2023 under mutual separation agreement.","Lump-sum severance includes $89,175 target bonus and $28,762 for COBRA premiums.","Accelerated vesting of unvested equity eligible to vest by July 1, 2023; remainder forfeited.","Holland remains bound by non-competition, IP, and confidentiality agreements.","Agreement includes cooperation with transition and release of all claims against Electromed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":296094,"accession_number":"0000897101-23-000235","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2023-06-05T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Electromed names Jim Cunniff as CEO effective July 1, 2023; Kathleen Skarvan to become Chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["James L. Cunniff appointed President & CEO, effective July 1, 2023; also joins Board.","Base salary of $500k; eligible for annual bonus (50% target), plus initial equity grants of 175k RSUs and 175k options.","Current CEO Kathleen Skarvan retires but remains as Chair of the Board; director Lee Jones not standing for re-election.","Board size increased from 8 to 9 to accommodate Cunniff; Jones to serve until November 2023 annual meeting.","Cunniff brings over 30 years MedTech experience; most recently CEO of Provista."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":296093,"accession_number":"0000897101-23-000193","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2023-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Electromed Q3 FY2023 net revenue $12.1M (+19% YoY); diluted EPS $0.12","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record quarterly net revenue of $12.1M, up 19% YoY; homecare revenue $11.0M (+21%).","Net income $1.1M ($0.12 diluted EPS) vs $645K ($0.07) a year ago, up 67%.","Operating income $1.2M, up 39% YoY; gross margin 75.0% vs 76.4%.","Cash balance $6.8M as of March 31, 2023; working capital $28.8M.","Launched next-gen SmartVest Clearway; field sales force 57, productivity within target $850K-$950K."],"consensus_eps_estimate":null,"consensus_eps_actual":0.25,"consensus_revenue_estimate":null,"consensus_revenue_actual":34455000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":316612,"accession_number":"0000897101-23-000086","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2023-02-14T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Electromed reports record Q2 revenue of $11.7M (+15% YoY); CEO Skarvan to retire July 1, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Q2 FY2023 net revenue of $11.7M (record), up 15% YoY; net income of $977k ($0.11 diluted) vs $838k ($0.10).","Homecare revenue up 14% to $10.7M; operating income $1.3M vs $1.1M.","CEO Kathleen Skarvan to retire on/about July 1, 2023; will become Board Chair; search for successor underway.","Cash $6.9M; next-gen SmartVest Clearway FDA-cleared; Brad Nagel appointed CFO in Nov 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":334868,"accession_number":"0000897101-22-001004","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2022-11-17T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Electromed shareholders elect directors, ratify auditor, approve executive comp at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All eight director nominees elected; highest votes for Kathleen Skarvan (4,385,793), lowest for Lee Jones (3,032,167).","Ratification of RSM US LLP as auditor for FY2023: 5,522,296 for, 6,431 against, 546,328 abstain.","Non-binding advisory vote on executive compensation approved: 4,312,956 for, 170,780 against, 545,430 abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":334867,"accession_number":"0000897101-22-000946","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2022-11-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Electromed Q1 FY2023 revenue up 7% to $10.7M; net income drops to $0.01 EPS","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $10.7M, +7% YoY; net income $81K ($0.01 diluted EPS) vs $439K ($0.05) last year.","Operating income $44K vs $538K a year ago; SG&A up 17.7% due to legal fees and annual sales meeting.","Cash $6.0M, down $2.2M from June 30; repurchased $145K of stock in quarter.","Next-generation 510(k) submitted to FDA; limited market release expected in fiscal Q2 if clearance by mid-Dec."],"consensus_eps_estimate":null,"consensus_eps_actual":0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":10658000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":334866,"accession_number":"0000897101-22-000900","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2022-10-24T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Electromed appoints Brad Nagel as CFO effective Nov 14, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brad Nagel, formerly Divisional CFO at Medtronic, will serve as CFO, Treasurer, Secretary.","Michelle Wirtz, interim CFO, returns to Corporate Controller role.","Nagel receives $250,000 base salary, 30% target bonus, 5,000 restricted stock grant.","Nagel brings 15+ years financial leadership from Medtronic, Target, TCF Bank."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":352303,"accession_number":"0000897101-22-000804","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2022-08-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Electromed reports record annual revenue of $41.7M (+16.5% YoY); Q4 revenue $11.3M (+19%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 FY2022 net revenue $11.3M (+19% YoY); net income $0.4M ($0.04 diluted EPS).","FY2022 net revenue $41.7M (+16.5% YoY); net income $2.3M ($0.26 diluted EPS).","Home care revenue grew 21.6% in Q4; direct sales reps increased from 37 to 43.","Share repurchase: $0.5M at avg $12.10/share; cash $8.2M, no debt.","FY2023 outlook: revenue growth mid-to-high teens; next-gen SmartVest pending FDA clearance with limited market release in fiscal Q2."],"consensus_eps_estimate":null,"consensus_eps_actual":0.26,"consensus_revenue_estimate":null,"consensus_revenue_actual":41659000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":352302,"accession_number":"0000897101-22-000698","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2022-07-25T23:59:59+00:00","items":["1.01","5.02","7.01","9.01"],"status":"ready","headline":"Electromed adds Andrew Summers to board, enters cooperation with Summers Value Partners","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Elects Andrew Summers as independent director, effective July 25, 2022; board expands from seven to eight members.","Enters cooperation agreement with Summers Value Partners, which owns ~6.1% of ELMD outstanding common stock.","Agreement includes standstill restrictions and voting commitments; Summers to be nominated for election at FY 2023 annual meeting.","Summers appointed Vice Chair of Finance and Strategy Committee and member of Nominating and Governance Committee.","Summers founded Summers Value Partners in 2018; has 22 years of healthcare investing experience."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":369831,"accession_number":"0000897101-22-000581","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2022-06-07T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Electromed appoints Michelle Wirtz as Interim CFO; base salary $220K, 30% target bonus","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michelle C. Wirtz promoted to Interim CFO, Treasurer and Secretary effective June 1, 2022.","New annual base salary of $220,000; eligible for bonus with 30% of base target from FY2023.","For a non-cause termination within 12 months after a change of control, she receives 100% base salary plus pro-rated company-performance bonus and 12 months COBRA premium continuation.","Former CFO Michael J. MacCourt ceased those roles on June 1, 2022; remains employed through July 1, 2022 for transition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":369830,"accession_number":"0000897101-22-000481","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2022-05-10T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Electromed Q3 revenue $10.1M (+15.4% YoY); CFO MacCourt to resign, Wirtz as interim CFO","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $0.6M ($0.07 diluted EPS) vs $0.2M ($0.03) in prior year quarter.","Gross margin 76.4% stable; cash $9.8M; repurchased 24,551 shares for $299k.","CFO Michael MacCourt resigns effective July 1, 2022; Michelle Wirtz appointed Interim CFO from June 1.","Christopher Holland hired as Chief Commercial Officer to lead growth initiatives.","Home care revenue per direct rep annualized at $943k, above $800-900k target range."],"consensus_eps_estimate":null,"consensus_eps_actual":0.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":30390000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":388961,"accession_number":"0000897101-22-000087","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2022-02-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Electromed Q2 revenue record $10.2M (+7.9% YoY); EPS $0.10 vs $0.13","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Home care revenue $9.4M (+5.6% YoY); annualized revenue per direct sales rep $951K above target.","Gross margin 76.9% vs 79.2% due to higher raw material and shipping costs.","Operating income $1.1M vs $1.6M; net income $0.8M ($0.10 diluted) vs $1.2M ($0.13).","Cash $10.5M; repurchased 55,687 shares for $663K during quarter.","CEO cites strategic investments in sales force, marketing, and next-gen SmartVest development."],"consensus_eps_estimate":null,"consensus_eps_actual":0.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":20249000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":406891,"accession_number":"0000897101-21-000999","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2021-12-17T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Electromed renews $2.5M revolving credit line with Choice Financial, maturity to Dec 2023","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Line of credit extended for two years, now matures on December 18, 2023.","Interest rate remains at prime minus 1.00%, no floor, payable monthly.","Borrowing base limited to the lesser of $2.5M or 57% of eligible accounts receivable.","Obligations secured by substantially all tangible and intangible assets of the Company.","Rider includes multiple amendments to loan agreement terms, such as default triggers and collateral provisions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":406890,"accession_number":"0000897101-21-000955","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2021-11-17T23:59:59+00:00","items":["5.07","7.01"],"status":"ready","headline":"Electromed elects seven directors, appoints Lee A. Jones as Board Chair at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven director nominees elected; Lee A. Jones received 3,479,584 votes for, 862,668 withheld.","Ratification of RSM US LLP as independent auditor for FY2022: 5,431,896 for, 6,782 against, 563 abstain.","Advisory approval of executive compensation: 4,161,610 for, 172,939 against, 7,703 abstain, 1,096,989 broker non-votes.","Board appointed Lee A. Jones as Chair; committee memberships set for Audit, Finance, Nominating, and Compensation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":406889,"accession_number":"0000897101-21-000913","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2021-11-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Electromed Q1 FY2022 revenue hits record $10.0M, up 25% YoY; EPS $0.05 vs $0.06","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $10.0M, record quarterly; home care up 24.4% to $9.3M, institutional up 61.5% to $449K.","Net income $439K ($0.05 diluted EPS) vs $535K ($0.06) prior year; operating income $538K vs $663K.","Gross margin 77.0% vs 76.8%; SG&A rose to 67.9% of revenue due to strategic investments and shareholder activism costs.","Cash $11.0M, no debt; field sales employees 51 (41 direct reps), with record annualized home care revenue per rep of $955K.","Next-gen airway clearance device expected to launch in first half of FY2023 after FDA 510(k) clearance."],"consensus_eps_estimate":null,"consensus_eps_actual":0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":10001000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":425890,"accession_number":"0000897101-21-000771","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2021-09-27T23:59:59+00:00","items":["1.01","5.02","7.01","9.01"],"status":"ready","headline":"Electromed reaches cooperation agreement with Summers Value Partners; nominates two new directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Summers Value Partners (beneficial owner of ~5.9% of ELMD) withdraws proxy contest; enters standstill and voting pact.","Electromed will nominate Kathleen Tune and Joseph Galatowitsch for election at Fiscal 2022 Annual Meeting in November 2021.","Directors Steve Craney and George Winn to retire at Annual Meeting; Board remains at 7 directors.","New Finance and Strategy Committee formed after Annual Meeting, chaired by Tune, to review strategy, M&A, and capital allocation.","Board will elect a new independent Chair immediately following the Annual Meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":425889,"accession_number":"0000897101-21-000725","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2021-08-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Electromed Q4 revenue up 37.7% to $9.5M; full-year net income $2.4M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 FY2021 net revenue $9.5M (+37.7% YoY); home care revenue up 33.6%, institutional up 90.6%.","Q4 net income $0.4M ($0.04 diluted EPS) vs $1.3M ($0.15) in Q4 FY2020; prior year included $0.9M CARES Act stimulus.","Full-year FY2021 revenue $35.8M (+10.1% YoY); net income $2.4M ($0.27 diluted EPS) vs $4.2M ($0.47) in FY2020.","Operating cash flow $3.1M; cash $11.9M at June 30, 2021; no debt.","Repurchased $1.1M in stock under new $3.0M program; targeting HFCWO market share growth in FY2022."],"consensus_eps_estimate":null,"consensus_eps_actual":0.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":35756000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":425888,"accession_number":"0000897101-21-000674","cik":1488917,"company_name":"Electromed, Inc.","ticker":"ELMD","form_type":"8-K","filed_at":"2021-08-09T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Electromed expects Q4 FY2021 net revenue $9.3-9.5M, 37% YoY growth; discloses data privacy incident","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Preliminary net revenue $9.3-9.5M vs $6.9M in Q4 FY2020, driven by strong home care revenue growth.","Operating income expected $0.5-0.7M vs $1.3M last year, which included $0.9M CARES Act stimulus.","Cash $11.9M, no debt as of June 30, 2021.","Data privacy incident: unauthorized third party accessed files containing protected health information and associate SSNs; no evidence of misuse, credit monitoring offered.","Company taking steps to enhance security and providing external call center for inquiries."],"consensus_eps_estimate":null,"consensus_eps_actual":0.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":35756000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":323170906.44824886,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}